Ads
-
Related paper
- Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
- Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes
- Evaluate the Efficacy of Metformin and Glimepiride with Metformin in Patients with Type II Diabetes Mellitus
- The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
- Combination Therapy with Metformin plus Gliclazide in Patients with Type 2 Diabetes
- The Role of Metformin on Serum Vitamin B12 Levels in Patients with Type 2 Diabetes Mellitus
- “VITAMIN B12 DEFICIENCY IN TYPE 2 DIABETES PATIENTS ON LONG TERM METFORMIN THERAPY FOR > 2YEARS”
- Evaluation of thyroid hormone dysfunction in type - 2 diabetes patients on metformin therapy ? A cross sectional study
- Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
- “A TALE OF GENETIC VARIATION IN THE HUMAN SLC22A1 GENE ENCODING OCT1 AMONG TYPE 2 DIABETES MELLITUS POPULATION GROUPS OF WEST BENGAL, INDIA”